Vimarsana
Biggest News Aggregation in the World

Page 40 - Genetic Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetic Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetic Engineering Today - Breaking & Trending Today

Genetic Engineering in 'Gattaca' Movie Seems Ideal, But What Are Its Disadvantages? - Vimarsana News

Genetic Engineering in 'Gattaca' Movie Seems Ideal, But What Are Its Disadvantages?

In science fiction cinema, few films have delved as deeply into the ethical and philosophical implications of genetic engineering as "Gattaca."

Covid-19: Latin America defies nationalism and circumstance to develop its own vaccines - Vimarsana News

Covid-19: Latin America defies nationalism and circumstance to develop its own vaccines

Latin American countries not only developed their own covid vaccine prototypes but also rolled them out. Martín De Ambrosio reports on a region taking its first steps towards vaccine security When the pandemic shook the world in 2020, Argentina, like many countries, went into full lockdown. Juliana Cassataro, a researcher at the National University of General San Martín, wondered what her team could do to help. The answer was obvious for a researcher specialising in oral vaccines: make one. “From the beginning we planned to make it as a booster—we realised that we couldn’t compete with...

Source: bmj.com
Skills needed to pursue a career in Biotechnology - Vimarsana News

Skills needed to pursue a career in Biotechnology

Skills needed to pursue a career in Biotechnology

Can genome editing transform ocular disease treatment? - Vimarsana News

Can genome editing transform ocular disease treatment?

The discovery and development of gene-editing technologies and their applications in managing ocular diseases.

PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome - Vimarsana News

PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome

Planning underway for Phase 2 trial of LYT-300 in Fragile X-associated Tremor/Ataxia Syndrome LYT-300 is also being evaluated in a Phase 2a trial for anxiety disorders, and a Phase 2a in patients...